cardiovascular Latest News

Diabetes | Secondary Complications, Regulation and Innovation 1ST - 2ND October,

Thomas McLain Appointed as President and Chief Executive Officer for Vermillion, Inc.

AAMA announces Facebook and Twitter links, in addition to LinkdIn presence. Social Media activities to be increased.

Participating corporate and consulting firm exhibitors announced for the AAMA 3-in-1 Conference, including conference sponsor Amgen Oncology. Exhibit space still available. 3-in-1 Conference will be held at Bally's Las Vegas, April 10-12, 2013.

Jonathan Fialkow, M.D., a partner with Cardiovascular Center of South Florida, a member of the HeartWell LLP group practice of cardiologists, has been named medical director of clinical cardiology for Baptist Cardiac and Vascular Institute.

Representatives from Heart Test Laboratories traveled to Dusseldorf, Germany, to represent the company at MEDICA 2011, World Forum for Medicine International Trade Fair.

To earn the award, South Nassau needed to adhere to the treatment guidelines in ACTION Registry–GWTG for 12 consecutive quarters (three years) and meet a performance standard of at least 85% for specific performance measures.

How to select the most apporpriate formulation tool for poorly soluble drugs

Seventy-two fellows attended the New Cardiovascular Horizons (NCVH) Third Annual Fellows Course, Complex Strategies for Peripheral Interventions, on Tuesday, June 4, 2013, at the New Orleans Marriott.

Diabetes | Secondary Complications, Regulation and Innovation 1ST - 2ND October,

Thomas McLain Appointed as President and Chief Executive Officer for Vermillion, Inc.

AAMA announces Facebook and Twitter links, in addition to LinkdIn presence. Social Media activities to be increased.

Participating corporate and consulting firm exhibitors announced for the AAMA 3-in-1 Conference, including conference sponsor Amgen Oncology. Exhibit space still available. 3-in-1 Conference will be held at Bally's Las Vegas, April 10-12, 2013.

AAMA announces "3-in-1" Conference. Cardiovascular, Oncology and Neuroscience specialty groups in one cross-disciplinary educational event. Separate specalty tracks, one exhibit hall, combined keynote sessions. April 10-12, 2013, Bally's Las Vegas.

New Pharmaceuticals market report from GlobalData: "Cardiovascular Inflammation Global Clinical Trials Review, H2, 2012"

At the 2012 NHS Confederation conference held 20-22 June, Prof Malcolm Grant DBE, Chair of the NHS Commissioning Board, has confirmed that clinical networks will not be disrupted, but rather serve as a model for the future.

Recently published research from Netscribes, "Cardiovascular Pharmaceuticals Market in India 2012", is now available at Fast Market Research

PharmaFlare analyzed patient experiences with regard to bleeding risk associated with Pradaxa

Jonathan Fialkow, M.D., a partner with Cardiovascular Center of South Florida, a member of the HeartWell LLP group practice of cardiologists, has been named medical director of clinical cardiology for Baptist Cardiac and Vascular Institute.

The Cardiovascular Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the cardiovascular partnering deals and agreements entered into by the worlds leading healthcare companies.

Research shows Omega 7 Palmitoleic acid is 5 times stronger than omega 3 (EPA) fatty acids at lowering triglycerides

The rise in disease incidence rate boosts demand for innovative therapeutics

Chesterford Research Park’s health and fitness team kick start 2012 with two new classes

Matt Snelling joins Nucleus team to give additional motivational encouragement to gym members!

Representatives from Heart Test Laboratories traveled to Dusseldorf, Germany, to represent the company at MEDICA 2011, World Forum for Medicine International Trade Fair.

To earn the award, South Nassau needed to adhere to the treatment guidelines in ACTION Registry–GWTG for 12 consecutive quarters (three years) and meet a performance standard of at least 85% for specific performance measures.

How to select the most apporpriate formulation tool for poorly soluble drugs

Dylan had been on an artificial heart for nearly a year before receiving a heart transplant in June 2010. Just 21 years old, he had been dealing with heart problems since childhood which didn't leave him with a high quality of life.

Sutter Pacific Medical Foundation announced the addition of two new specialty care physicians. Robert Rho, M.D., joins the Foundation as a specialist in cardiovascular disease and electrophysiology. Jyoti Jain, M.D., is a psychiatrist

Netscribes (India) Pvt. Ltd., launches its Cardiac Pacemaker Industry India Report 2011 covering one of the emerging markets in India with strong growth prospects . It is a part of Netscribes’ Healthcare Series reports.

Advanced Applications to Drive Market Revenues to $583.6 Million By 2016

Two biomedical measurement companies merge to offer fully integrated cardiovascular measurement solutions for both pre-clinical and clinical products.

White Plains Hospital has been granted accreditation by the ICAEL for their Echocardiography Lab, recognizing the laboratory’s commitment to quality testing for heart disease diagnosis.

The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders

FEBICO Chlorella Vulgaris CV-66 contains levels of rich natural PPARs (Peroxisome proliferator activated receptor), and GLA which are much higher than the usual chlorella, which effectively reduces your risk of diseases.

Golf ‘Fore’ Your Heart Raises over $125,000 for Cardiovascular Health Institute

The Revo MRI™ SureScan® pacing system, the first and only pacemaker in the U.S. specifically designed for use in a MRI environment, was approved by the U.S. Food and Drug Administration (FDA) On February 8, 2011.

Gamma Therapeutics, an Oregon biotech venture announced its been awarded a Phase II SBIR grant from the NIH to commercialize its GammaCoeur CVD Risk Assay. The $1.1 M grant allows GT to complete development, testing & final FDA approval by 2012.

New Pharmaceuticals market report from Datamonitor: "Commercial Insight: Cardiovascular and Metabolic Market Forecast"

HeartSmart Technologies Eye Care Division is pleased to announce that Kathleen Andersen, OD and Niloufar Hedayat, OD of RSM Vision in Rancho Santa Margarita, California have joined the HeartSmart Associates Network.

FitMed Partners offers Lipid Plus testing to patients. Fifty percent of heart attack victims have normal cholesterol, proving a simple cholesterol check is not enough to establish good cardiovascular health.

In recent years, the prevalence rate of cardiovascular disease has increased year by year. According to the data issued by Ministry of Health of the People’s Republic of China, there were 20 million patients with coronary artery disease in China

Join cardiologist Brian Gross MD, Southern Oregon Cardiology, for “Heart Disease and Seniors,” on March 16 from 11:30 a.m. to 1 p.m. at the Smullin Health Education Center on the Rogue Valley Medical Center campus in Medford. Lunch is free.

This report is an essential source for in-depth information and data relating to the Germany cardiovascular devices market. It also offers detailed and comprehensive coverage of market revenue, volume

This medical equipment report is an essential source for key information and data relating to the Global cardiovascular devices market. The report provides overview of key trends, drivers and restraints

This report is an essential source for in-depth information and data relating to the US cardiovascular devices market. It also offers detailed

GlobalData’s “Spain Cardiovascular Devices Market Analysis and Forecasts to 2015” report provides key data, information and analysis on the Spain cardiovascular devices market. The report provides market landscape

GlobalData’s medical device report: “Australia Cardiovascular Devices Market Analysis and Forecasts to 2015” report provides key data, information and analysis on the Australia cardiovascular devices market.

GlobalData’s medical device report: “Canada Cardiovascular Devices Market Analysis and Forecasts to 2015” report provides key data, information and analysis on the Canada cardiovascular devices market.

The cardiovascular devices represent one of the major markets in the medical equipment industry. This market consists of Cardiac Rhythm Management (CRM) devices

GlobalData’s medical device report offering, “Republic of Korea Cardiovascular Devices Market Outlook to 2016” provides key market data on the Republic of Korea cardiovascular devices market.

GlobalData’s new report, “The UK Cardiovascular Devices Market Outlook to 2016” provides key market data on the United Kingdom cardiovascular devices market. The report provides value (USD million)

GlobalData’s medical equipment report, “Israel Cardiovascular Devices Market Outlook to 2016” provides key market data on the Israel cardiovascular devices market. The report provides value

GlobalData’s medical equipment report, “Mexico Cardiovascular Devices Market Outlook to 2016” provides key market data on the Mexico cardiovascular devices market. The report provides value

GlobalData’s medical equipment report, “Brazil Cardiovascular Devices Market Outlook to 2016” provides key market data on the Brazil cardiovascular devices market.

Now in its fifth year of publication, the latest release of Who’s Developing What in Cardiovascular Devices? provides the ideal opportunity to review the progress, and monitor the prospects, of both emerging and established industry participants

GlobalData’s medical device report offering, “China Cardiovascular Devices Market Outlook to 2016” provides key market data on the China cardiovascular devices market. The report provides value

Health Diagnostic Laboratory, Richmond, VA & Gamma Therapeutics,Portland, OR, biotech venture start-ups, are collaborating on the development of a novel cardiovascular disease diagnostic assay to assess CVD patient risk of heart attack or stroke.